Biobanking has become a fundamental component of modern biomedical research, particularly in advancing our understanding of neurological disorders.

By systematically collecting and preserving diverse biological samples, including induced pluripotent stem cells, the National Institute of Neurological Disorders and Stroke (NINDS) provides critical resources for researchers investigating complex conditions like Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS).

As the demands of personalized medicine and innovative analytical techniques grow, biobanks must evolve to ensure continued sample integrity, security, and accessibility. Collaborations with state-of-the-art facilities such as SAMPLED enable NINDS to meet these challenges, supporting robust research infrastructure that enhances the quality of scientific inquiry and accelerates the development of effective therapies and management strategies for neurological diseases.